Jan Oscarsson

AstraZeneca (Netherlands) · NL

Area of research

Endocrinology, Diabetes and Metabolism · Epidemiology

Research interest

Research interests include Growth Hormone and Insulin-like Growth Factors, Diabetes Treatment and Management, Liver Disease Diagnosis and Treatment, and Metabolism, Diabetes, and Cancer.

h-index

citations

8,794

works

208

NIH funding

—

primary concept

Medicine

✉ Find email ↗

Recent publications

Effects of dietary fat profile on gut permeability and microbiota and their relationships with metabolic changes in mice

Obesity 2015cited by 216position: middledoi

The Beneficial Effects of n-3 Polyunsaturated Fatty Acids on Diet Induced Obesity and Impaired Glucose Control Do Not Require Gpr120

PLoS ONE 2014cited by 72position: lastdoi

Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice

PLoS ONE 2012cited by 605position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yan Y. Lam · Rutgers, The State University of New Jersey3 papers (2012–2015)Nicholas H. Hunt · University of Sydney2 papers (2012–2015)David I. Cook · The University of Sydney2 papers (2012–2015)L. H. Storlien · University of Sydney2 papers (2012–2015)Anuwat Dinudom · University of Sydney2 papers (2012–2015)Connie Ha · Denali Therapeutics (United States)2 papers (2012–2015)Ian D. Caterson · Monash University2 papers (2012–2015)Andrew Holmes · University of Pittsburgh2 papers (2012–2015)— · 1 papers (2014–2014)Leonard H Storlien · University of Sydney1 papers (2014–2014)Virginia M. Stone · Karolinska University Hospital1 papers (2014–2014)— · 1 papers (2014–2014)— · 1 papers (2014–2014)Mohammad Bohlooly‐Y · AstraZeneca (Brazil)1 papers (2014–2014)Noel G. Morgan · KU Leuven1 papers (2014–2014)Thomas J. Mather · University of Sydney1 papers (2015–2015)— · 1 papers (2014–2014)— · 1 papers (2014–2014)Andrew J. Mitchell · The University of Melbourne1 papers (2012–2012)— · 1 papers (2014–2014)